Company intelligence / Profile preview

Symptoma

Salzburg, Salzburg State, Austriasymptoma.com ↗

Ownership: Private
Development stage: Commercial

Overview

Symptoma’s AI-based symptom checker has been validated in multiple studies—including standardized testing with hundreds of cases led by the University Hospital of Salzburg—and has received awards for research excellence. It was notably used during the COVID‑19 pandemic for differentiating symptoms and was featured as a role-model technology by the European Parliament.

The system helps both patients and clinicians identify possible causes for symptoms using an extensive medical knowledge base built over nearly two decades of research.

No clinical trial results are relevant as it does not develop drugs or biologics.

Therapeutic areas: Other
Modalities: Device (AI-powered digital tool)
Industry: Digital Health Medical Devices

Partnerships

City of Vienna (COVID‑19 study collaboration)

Beyond the preview

Go deeper on Symptoma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Symptoma.

Explore the full profile